Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Innoviva Inc (INVA)

$10.83 0.10 (0.91%)

16:07 EDT INVA Stock Quote Delayed 15 Minutes

Volume:

Previous Close $10.83

Market Cap 1.10B

PE Ratio 8.40

EPS 1.29

Volume (Avg. Vol.) 305,600

Day's Range 10.72 - 11.03

52-Week Range 10.03 - 20.54

Dividend & Yield N/A (N/A)

INVA Stock Predictions, Articles, and Innoviva Inc News

From InvestorPlace
From the Web

5 Undervalued Stocks to Buy

By Chris Lau, InvestorPlace Contributor Sep 19, 2019

These undervalued stocks have been hit hard lately, but they still have what it takes to make a comeback, making them solid stocks to buy.

10 Small-Cap Stocks That Look Like Bargains

By James Brumley, InvestorPlace Feature Writer Jun 28, 2019

Petmed, Innoviva and Pitney Bowes are among some of the best small-cap stocks to buy now, after a recent drubbing.

10 Risky (But Rewarding) Small-Cap Stocks to Buy Now

By James Brumley, InvestorPlace Feature Writer Apr 5, 2019

These ten stocks aren't exactly household names, but they each deserve a spot in a list of small-cap stocks to buy now for traders that can deal with the risk for the potential of high reward.

GlaxoSmithKline and Innoviva look for new Trelegy use

From Seeking Alpha Oct 2, 2019

GlaxoSmithKline (NYSE:GSK) and Innoviva (NASDAQ:INVA) announce the filing of a supplemental new drug application to the FDA for an additional indication for the use of Trelegy Ellipta for asthma in a

The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave

From Benzinga Sep 27, 2019

The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 26.) AstraZeneca plc (...

The Daily Biotech Pulse: PhaseBio Leaps On Trial Results, Pacira Set To Join SmallCap 600 Index, Positive Readout For Amgen's Blood Cancer Drug

From Benzinga Sep 25, 2019

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 24) Bioanalytical Systems,...

Innoviva Enters Oversold Territory

From Market News Video Aug 23, 2019

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Notable Thursday Option Activity: TWNK, SLB, INVA

From Market News Video Aug 8, 2019

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Hostess Brands Inc (TWNK), where a total volume of 4,482 contracts has been traded thus far today, a contract volume which is representative of approximately 448,200 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 46.3% of TWNK's average daily trading volume over the past month, of 967,155 shares..

The Daily Biotech Pulse: Obseva Gets The Greenlight, Verastem Climbs On Licensing Deal, Merit Medical Earnings Disappoint

From Benzinga Jul 26, 2019

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 25) Akero Therapeutics Inc (...

Navellier Ratings

Powered by Portfolio Grader

Total Grade

D

Sell

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!